Home › Chronic Inflammatory Demyelinating Polyradiculoneuropathy › Pennsylvania › Philadelphia
Chronic Inflammatory Demyelinating Polyradiculoneuropathy clinical trials in Philadelphia, PA
5 studies for Chronic Inflammatory Demyelinating Polyradiculoneuropathy are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
RecruitingPhase 2
- Site Number - 1616, Philadelphia
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
RecruitingPhase 3
- Penn Medicine University City, Philadelphia
- Jefferson Health Honickman Center, Philadelphia
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
RecruitingPhase 3
- Perelman Center for Advanced Medicine, Philadelphia
- Jefferson Health Honickman Center, Philadelphia
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
RecruitingPhase 3
- Penn Medicine: University of Pennsylvania Health System- Site Number : 8400022, Philadelphia
A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
RecruitingPhase 2
- Penn Blood Disorders Program - Hospital of The University of Pennsylvania, Philadelphia
Chronic Inflammatory Demyelinating Polyradiculoneuropathy trials in other cities
- New York City, NY7 studies
- Houston, TX6 studies
- Miami, FL6 studies
- New Haven, CT5 studies
- Indio, CA5 studies
- St. Louis, MO5 studies
- Kansas City, KS5 studies
- San Francisco, CA4 studies
- Tampa, FL4 studies
- Orlando, FL4 studies
- Birmingham, AL4 studies
- Washington, DC4 studies
Other studies in Philadelphia
- Cancer (all types)59 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Prostate Cancer44 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer28 studies
- Depression26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.